| Overview |
| bsm-33089M-APC-Cy7 |
| IDE Monoclonal Antibody, APC-Cy7 Conjugated |
| WB |
| Human |
| Specifications |
| APC-Cy7 |
| Mouse |
| KLH conjugated synthetic peptide derived from human IDE |
| Monoclonal |
| 5H4 |
| IgG |
| 1ug/ul |
| Purified by Protein G. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 3416 |
| P14735 |
| Extracellular, Cytoplasm, Cytomembrane |
| BC2; Insulin degrading enzyme; FLJ35968; insulin protease; insulinase; insulysin; Abeta-degrading protease; FLJ35968; Ide; IDE_HUMAN; Insulin-degrading enzyme; OTTHUMP00000020097. |
| Plays a role in the cellular breakdown of insulin, IAPP, glucagon, bradykinin, kallidin and other peptides, and thereby plays a role in intercellular peptide signaling. Degrades amyloid formed by APP and IAPP. May play a role in the degradation and clearance of naturally secreted amyloid beta-protein by neurons and microglia. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz